Rare diseases
Investigational molecules
Locations
Back to Germany28 clinical trials in Langenau, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Long-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyA study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.
GermanyA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
GermanyLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
GermanyStudy on the Effectiveness and Safety of JNJ-77242113 for Patients with Active Psoriatic Arthritis Who Have Previously Used Biologic Treatments
GermanyStudy on the Effectiveness of Green Tea Leaf Extract Ointment for Adults with Actinic Keratosis on the Scalp and Face
GermanyStudy on the Effectiveness and Safety of Ivermectin Cream Compared to a Drug Combination for Patients with Papulopustular Rosacea
GermanyStudy on the Effectiveness and Safety of Clindamycin and Tretinoin Gel for Patients with Papulopustular Acne
GermanyStudy on Treating Scabies with Permethrin and Ivermectin for Patients with Scabies
GermanyStudy on the Effectiveness of JNJ-77242113 and Deucravacitinib for Treating Moderate to Severe Plaque Psoriasis in Adults
GermanyLong-term safety and effectiveness study of sonelokimab injections for patients with moderate to severe hidradenitis suppurativa
GermanyStudy on the Effectiveness and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab for Patients with Moderate to Severe Plaque Psoriasis
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on plaque psoriasis and psoriatic arthritis, evaluating novel therapeutic approaches for both biologic-naive and experienced patients. Studies aim to assess treatment efficacy in reducing disease symptoms and improving patient outcomes.
Multiple investigations are comparing new therapeutic agents against placebo and established treatments.
Comprehensive studies addressing hidradenitis suppurativa and atopic dermatitis. Research focuses on evaluating new treatments for these challenging conditions, with emphasis on both immediate efficacy and long-term management.
Trials are examining both topical and systemic treatments for optimal disease control.
Innovative research addressing various skin conditions including chronic venous ulcers, actinic keratosis, and rosacea. Studies range from stem cell therapies for wound healing to novel topical treatments.
Research includes both traditional and cutting-edge therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
